Health Care: Drugs

Rigel Pharmaceuticals Inc (RIGL: NASDAQ)

$3.43 n/a | n/a%
03/27/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 20.38M 28.89M 8.25M 7.15M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 20.38M 28.89M 8.25M 7.15M
Selling, General, and Administrative Expenses 20.91M 17.81M 22.50M 19.61M
Research & Development 63.45M 62.83M 67.70M 75.33M
Operating Income before D & A (EBITDA) -63.97M -51.74M -81.95M -87.79M
Depreciation & Amortization 1.06M 1.44M 2.36M 2.59M
Interest Income 437.00K 222.00K 243.00K 426.00K
Other Income - Net 88.00K 57.00K -9.20M 16.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -70.27M -52.90M -93.27M -91.62M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -70.27M -52.90M -93.27M -91.62M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -69.22M -51.46M -90.91M -89.03M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -69.22M -51.46M -90.91M -89.03M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -69.22M -51.46M -90.91M -89.03M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-63.45M -51.46M -90.91M -87.35M
Preferred Dividends
Net Income Available To Common -69.22M -51.46M -90.91M -89.03M
Basic EPS from Continuing Ops. -0.73 -0.58 -1.04 -1.02
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.73 -0.58 -1.04 -1.02
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.73 -0.58 -1.04 -1.02
Basic Normalized Net Income/Share -0.67 -0.58 -1.04 -1.00
EPS fr Continuing Ops. -0.73 -0.58 -1.04 -1.02
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.73 -0.58 -1.04 -1.02
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.73 -0.58 -1.04 -1.02
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.67 -0.58 -1.04 -1.00
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with RIGL

Latest RIGL Headlines from TheStreet

More Financial News for RIGL

Press Releases for RIGL

See All Press Releases

Partner Headlines for RIGL

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter